CryoCell Total Current Liabilities vs Common Stock Analysis

CCEL Stock  USD 8.35  0.05  0.60%   
CryoCell International financial indicator trend analysis is way more than just evaluating CryoCell International prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CryoCell International is a good investment. Please check the relationship between CryoCell International Total Current Liabilities and its Common Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.

Total Current Liabilities vs Common Stock

Total Current Liabilities vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CryoCell International Total Current Liabilities account and Common Stock. At this time, the significance of the direction appears to have very strong relationship.
The correlation between CryoCell International's Total Current Liabilities and Common Stock is 0.89. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Common Stock in the same time period over historical financial statements of CryoCell International, assuming nothing else is changed. The correlation between historical values of CryoCell International's Total Current Liabilities and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of CryoCell International are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Total Current Liabilities i.e., CryoCell International's Total Current Liabilities and Common Stock go up and down completely randomly.

Correlation Coefficient

0.89
Relationship DirectionPositive 
Relationship StrengthStrong

Total Current Liabilities

Total Current Liabilities is an item on CryoCell International balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of CryoCell International are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Common Stock

Most indicators from CryoCell International's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CryoCell International current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.The value of Selling General Administrative is expected to slide to about 11.2 M. Tax Provision is expected to rise to about (3.3 M) this year
 2021 2022 2023 2024 (projected)
Gross Profit21.5M22.9M26.3M27.7M
Total Revenue30.3M31.3M36.0M18.4M

CryoCell International fundamental ratios Correlations

0.830.940.10.790.57-0.030.74-0.090.970.75-0.050.88-0.490.970.020.970.320.50.660.080.61-0.270.870.990.96
0.830.850.150.670.36-0.110.67-0.140.840.53-0.130.64-0.240.760.220.790.130.690.360.320.29-0.130.750.810.69
0.940.85-0.150.750.55-0.290.83-0.040.90.650.00.94-0.330.950.180.970.350.410.660.160.55-0.120.890.960.89
0.10.15-0.15-0.13-0.450.78-0.420.240.120.380.19-0.28-0.17-0.13-0.2-0.13-0.050.6-0.40.040.08-0.38-0.080.010.07
0.790.670.75-0.130.74-0.20.9-0.630.870.41-0.60.69-0.340.850.160.83-0.160.150.510.190.12-0.130.660.80.67
0.570.360.55-0.450.74-0.280.69-0.630.590.14-0.580.57-0.40.71-0.080.670.020.00.84-0.040.30.010.530.580.56
-0.03-0.11-0.290.78-0.2-0.28-0.440.23-0.010.210.21-0.35-0.6-0.18-0.75-0.21-0.070.29-0.18-0.340.25-0.5-0.19-0.130.05
0.740.670.83-0.420.90.69-0.44-0.460.780.3-0.410.78-0.270.840.20.85-0.010.00.550.150.140.020.70.780.65
-0.09-0.14-0.040.24-0.63-0.630.23-0.46-0.260.250.990.03-0.03-0.2-0.19-0.160.630.17-0.12-0.170.5-0.14-0.03-0.090.07
0.970.840.90.120.870.59-0.010.78-0.260.74-0.230.81-0.450.940.040.940.070.50.570.120.46-0.30.830.960.88
0.750.530.650.380.410.140.210.30.250.740.260.64-0.310.65-0.040.660.210.520.350.110.66-0.270.630.750.76
-0.05-0.130.00.19-0.6-0.580.21-0.410.99-0.230.260.08-0.08-0.15-0.22-0.110.680.13-0.05-0.220.54-0.130.01-0.050.12
0.880.640.94-0.280.690.57-0.350.780.030.810.640.08-0.340.930.160.940.460.210.750.060.64-0.120.840.930.89
-0.49-0.24-0.33-0.17-0.34-0.4-0.6-0.27-0.03-0.45-0.31-0.08-0.34-0.480.8-0.45-0.24-0.13-0.550.51-0.630.54-0.36-0.43-0.62
0.970.760.95-0.130.850.71-0.180.84-0.20.940.65-0.150.93-0.480.041.00.30.320.760.050.58-0.20.870.980.94
0.020.220.18-0.20.16-0.08-0.750.2-0.190.04-0.04-0.220.160.80.040.08-0.070.05-0.250.63-0.440.420.140.1-0.16
0.970.790.97-0.130.830.67-0.210.85-0.160.940.66-0.110.94-0.451.00.080.320.350.740.080.57-0.180.880.990.94
0.320.130.35-0.05-0.160.02-0.07-0.010.630.070.210.680.46-0.240.3-0.070.320.110.47-0.130.680.040.350.320.49
0.50.690.410.60.150.00.290.00.170.50.520.130.21-0.130.320.050.350.110.120.140.35-0.360.420.440.41
0.660.360.66-0.40.510.84-0.180.55-0.120.570.35-0.050.75-0.550.76-0.250.740.470.12-0.180.73-0.090.650.680.76
0.080.320.160.040.19-0.04-0.340.15-0.170.120.11-0.220.060.510.050.630.08-0.130.14-0.18-0.250.670.130.1-0.07
0.610.290.550.080.120.30.250.140.50.460.660.540.64-0.630.58-0.440.570.680.350.73-0.25-0.30.570.60.78
-0.27-0.13-0.12-0.38-0.130.01-0.50.02-0.14-0.3-0.27-0.13-0.120.54-0.20.42-0.180.04-0.36-0.090.67-0.3-0.2-0.23-0.29
0.870.750.89-0.080.660.53-0.190.7-0.030.830.630.010.84-0.360.870.140.880.350.420.650.130.57-0.20.890.84
0.990.810.960.010.80.58-0.130.78-0.090.960.75-0.050.93-0.430.980.10.990.320.440.680.10.6-0.230.890.95
0.960.690.890.070.670.560.050.650.070.880.760.120.89-0.620.94-0.160.940.490.410.76-0.070.78-0.290.840.95
Click cells to compare fundamentals

CryoCell International Account Relationship Matchups

CryoCell International fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets46.2M60.7M64.9M61.2M70.4M73.9M
Other Current Liab1.9M8.0M5.2M4.9M5.7M6.0M
Total Current Liabilities16.4M21.1M19.5M20.9M24.0M25.2M
Total Stockholder Equity(2.7M)4.2M(1.5M)(11.0M)(9.9M)(9.4M)
Property Plant And Equipment Net1.9M4.1M14.2M22.0M25.3M26.6M
Net Debt(4.1M)(5.4M)9.9M10.5M9.4M9.0M
Retained Earnings(18.8M)(16.7M)(21.6M)(31.2M)(28.0M)(29.4M)
Accounts Payable957.4K1.5M1.6M3.2M3.7M3.8M
Cash10.4M8.3M1.7M406.1K467.0K443.6K
Non Current Assets Total27.6M44.9M55.3M51.8M59.5M62.5M
Non Currrent Assets Other11.6M10.3M9.9M6.3M7.3M7.6M
Cash And Short Term Investments10.4M8.3M1.7M980.3K1.1M1.1M
Net Receivables6.3M5.3M6.0M6.6M7.6M7.9M
Common Stock Shares Outstanding8.1M8.4M8.5M8.3M7.5M7.8M
Liabilities And Stockholders Equity46.2M60.7M64.9M61.2M70.4M73.9M
Non Current Liabilities Total32.5M35.4M46.9M51.4M59.1M62.1M
Other Stockholder Equity16.0M20.8M20.0M20.0M23.0M21.5M
Total Liab48.9M56.5M66.4M72.3M83.1M87.2M
Total Current Assets18.6M15.8M9.6M9.5M10.9M10.5M
Intangible Assets1.5M16.2M15.2M989.1K1.1M2.0M
Short Long Term Debt Total6.2M2.8M11.6M10.9M9.8M9.3M
Other Current Assets856.3K1.3M993.4K1.1M1.3M871.7K
Short Term Debt3.4M2.2M2.7M1.6M1.9M1.6M
Short Term Investments88.5K75.4K17.6K574.2K516.8K641.7K
Common Stock136.3K146.7K148.5K148.5K170.8K134.7K
Other Liab28.6M29.6M34.8M38.0M43.7M45.9M
Other Assets22.2M21.9M22.3M23.7M27.2M28.6M
Long Term Debt5.9M2.8M8.6M8.4M9.7M5.2M
Property Plant Equipment1.8M1.6M4.1M14.2M16.3M17.2M
Current Deferred Revenue9.2M9.4M9.6M9.7M11.2M6.4M
Net Tangible Assets(10.1M)(2.7M)(14.0M)(18.6M)(16.8M)(17.6M)
Non Current Liabilities Other32.5M3.5M2.0M919.2K827.3K785.9K
Inventory927.3K921.2K851.2K768.9K692.0K657.4K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.625
Earnings Share
(1.07)
Revenue Per Share
3.89
Quarterly Revenue Growth
0.025
Return On Assets
(0)
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.